Roche's strong U.S. presence and diversified product portfolio may mitigate the impact of potential tariffs, making it a ...

In a report released on April 9, Tim Anderson from Bank of America Securities maintained a Buy rating on Eli Lilly and ...

British industry leaders fear tariffs imposed by President Trump could disrupt the supply and even the price of drugs ...

The obesity drug market has experienced a seismic shift in recent years, with Novo Nordisk's (NOV: N) Wegovy (semaglutide) ...

The market for anti-obesity drugs has been growing for a while, but is finally about to take off with the entry of two global ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...

Eli Lilly's foray into telehealth shows the emerging importance virtual care platforms are playing in the rising popularity ...

Experts concerned over promotional strategies of Eli Lilly for tirzepatide: Shardul Nautiyal, Mumbai Friday, April 11, 2025, 08:00 Hrs [IST] As Mounjaro (tirzepatide), the blockbu ...

Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), American ...

Weight loss platform Noom launched a full-page print ad in The Wall Street Journal this week, calling on policymakers to create new guidance around expensive drugs, as compounded GLP-1s are set to be ...

A woman felt like she was being "ripped open by a knife" after suffering extreme reaction to single weight loss jab Mounjaro.